Hyperkalemia and Renin –Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction

Heart failure (HF) affects 1 –2% of the population in developed countries and absorbs a significant amount of human and economic resources.1,2 HF is a complex syndrome characterised by a spectrum of symptoms and phenotypes: HF with preserved ejection fraction, HF with mid-range ejection fraction and HF with reduced ejection fraction (HFrEF).3 Differentiating patients according to left ventricular ejection fraction (LVEF) is relevant as these syndromes have distinct patterns of under
Source: Radcliffe Cardiology - Category: Cardiology Authors: Source Type: research